HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GNC Soy Consumer Education Campaign Debuting In Early November

This article was originally published in The Tan Sheet

Executive Summary

General Nutrition Centers is installing free-standing "Soy Centers" in more than 4,200 stores nationwide as part of a consumer health education campaign on the increasingly popular nutrition source. The campaign, entitled "Soy You Can Enjoy," is launching the week of Nov. 1.

You may also be interested in...



Weider Soy Powder With Once-Daily Dosing Joining Schiff Line April 1

Weider Nutrition will extend its Schiff line of products in April with the introduction of Soy One powdered drink mix, as well as MSM 500 and Glucosamine MSM Complex. The items debuted at the Natural Products Expo West show in Anaheim, Calif. March 23-26.

Soy Protein Health Claim For Reduced Heart Disease Clears FDA

Manufacturers may begin using a health claim for soy protein and the reduced risk of coronary heart disease (CHD) on food labeling immediately upon the expected publication of FDA's final rule in the Oct. 26 Federal Register.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS140524

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel